BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Noble Life Sciences Inc. Announces Appointment of Alain Cappeluti as President


1/9/2012 8:47:57 AM

GAITHERSBURG, MD--(Marketwire - January 09, 2012) -

Noble Life Sciences, a provider of preclinical research services to the biotechnology and pharmaceutical industries, announced today the appointment of Mr. Alain Cappeluti, as the company's President. At the same time, the company announced the appointment of Dr. Kenneth Carter as the Chairman of the Board of Noble Life Sciences.

"I am delighted to lead Noble Life Sciences' experienced and talented team as we launch new services to expand our current offering," said Mr. Cappeluti. "A focus of our development efforts has been to establish a biomarker based platform that leverages validated cancer pathway biomarkers measured in cell lines and tumor tissues to predict and evaluate sensitivity to targeted therapeutics across cancer indications and molecular sub-types. This effort has been supported by a Translational Research Award we received in 2010 from The Department of Business and Economic Development, Maryland Biotechnology Center."

Mr. Cappeluti has more than 25 years of experience in the biotech industry working for BioReliance, Human Genome Sciences (HGS), and CoGenesys. Mr. Cappeluti was the second employee at HGS and was part of the team that spun out CoGenesys from HGS in 2006 until the company was sold to Teva Pharmaceuticals in 2008. He has managed both large and small internal financial operations and has participated directly in approximately $4 billion of corporate financing transactions including private and public financings; IPOs; mergers and acquisitions; and real estate transactions. He is also a co-founder and serves on the board of OTraces, Inc., an early stage cancer diagnostics company and is on the board of and serves as a consultant to other life science companies.

Dr. Carter remarked, "I am very pleased to assume the duties of Chairman of the Board of Noble Life Sciences as I move on to a new position as President and CEO of NexImmune. Mr. Cappeluti will take the lead at Noble Life Sciences during a very exciting time as the company expands its presence in the Maryland biotechnology market."

About Noble Life Sciences:
Noble Life Sciences provides in vitro and in vivo preclinical research services including experimental design and testing, disease models, selection and validation of biomarkers for personalized medicine, and vivarium services. With deep expertise in preclinical drug development, the company offers access to their top scientists who work collaboratively with researchers in pharmaceutical, biotechnology, and diagnostic companies as well as those in academic and government institutions to expedite preclinical research and guide clinical development. For more information about Noble Life Sciences, visit www.noblelifesci.com.


Media Contact Information
Faye Coggins
800-602-9950



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES